Zobrazeno 1 - 10
of 87
pro vyhledávání: '"Masayo, Ogawa"'
Autor:
Morag Griffin, Shreyans Gandhi, Richard J. Kelly, Talha Munir, Roochi Trikha, Eden Hicks, Deepak Jain, Masayo Ogawa, Ji Yu, Petra Muus, Austin G. Kulasekararaj
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
Not available.
Externí odkaz:
https://doaj.org/article/bf9d9c4e9ebe48db8d6a619467f89d7d
Autor:
Bradley P. Dixon, David Kavanagh, Alvaro Domingo Madrid Aris, Brigitte Adams, Hee Gyung Kang, Edward Wang, Katherine Garlo, Masayo Ogawa, Praveen Amancha, Sourish Chakravarty, Nils Heyne, Seong Heon Kim, Spero Cataland, Sung-Soo Yoon, Yoshitaka Miyakawa, Yosu Luque, Melissa Muff-Luett, Kazuki Tanaka, Larry A. Greenbaum
Publikováno v:
Kidney Medicine, Vol 6, Iss 8, Pp 100855- (2024)
Rationale & Objective: Atypical hemolytic uremic syndrome (aHUS) is a rare form of thrombotic microangiopathy (TMA) caused by complement dysregulation. Ravulizumab is a C5i approved for the treatment of aHUS. This analysis assessed long-term outcomes
Externí odkaz:
https://doaj.org/article/7f561a99f7394b13a825a873ba0b2526
Autor:
Austin Kulasekararaj, Robert Brodsky, Morag Griffin, Alexander Röth, Caroline Piatek, Masayo Ogawa, Ji Yu, Yogesh Patel, Fernando Ataulfo Gonzalez Fernandez, Jun-Ichi Nishimura, Régis Peffault de Latour, Jeff Szer, Jong Wook Lee
Publikováno v:
HemaSphere, Vol 7, p e6327336 (2023)
Externí odkaz:
https://doaj.org/article/e22efa1c407e402c8e9bc16d030bff90
Autor:
Moto Nakaya, Noriko Sato, Hiroshi Matsuda, Norihide Maikusa, Yoko Shigemoto, Daichi Sone, Tensho Yamao, Masayo Ogawa, Yukio Kimura, Emiko Chiba, Masahiro Ohnishi, Koichi Kato, Kyoji Okita, Tadashi Tsukamoto, Yuma Yokoi, Masuhiro Sakata, Osamu Abe
Publikováno v:
Alzheimer’s & Dementia: Translational Research & Clinical Interventions, Vol 8, Iss 1, Pp n/a-n/a (2022)
Abstract Introduction Free‐water (FW) imaging, a new analysis method for diffusion magnetic resonance imaging (MRI), can indicate neuroinflammation and degeneration. We evaluated FW in Alzheimer's disease (AD) using tau/inflammatory and amyloid pos
Externí odkaz:
https://doaj.org/article/a60959aa3ffc4cc2bc1f5b8ad5cc253d
Autor:
Yoko Shigemoto, Daichi Sone, Miho Ota, Norihide Maikusa, Masayo Ogawa, Kyoji Okita, Harumasa Takano, Koichi Kato, Yukio Kimura, Emiko Morimoto, Fumio Suzuki, Hiroyuki Fujii, Noriko Sato, Hiroshi Matsuda
Publikováno v:
EJNMMI Research, Vol 9, Iss 1, Pp 1-5 (2019)
Abstract Backgrounds Although neurofibrillary tangles (NFTs) mainly accumulate in the medial temporal lobe with human aging, only a few imaging studies have investigated correlations between NFT accumulation and gray matter (GM) volume in cognitively
Externí odkaz:
https://doaj.org/article/345b807abd5e4fc78e6fbcde8ec1142a
Autor:
Hiroshi Matsuda, Kengo Ito, Kazunari Ishii, Eku Shimosegawa, Hidehiko Okazawa, Masahiro Mishina, Sunao Mizumura, Kenji Ishii, Kyoji Okita, Yoko Shigemoto, Takashi Kato, Akinori Takenaka, Hayato Kaida, Kohei Hanaoka, Keiko Matsunaga, Jun Hatazawa, Masamichi Ikawa, Tetsuya Tsujikawa, Miyako Morooka, Kenji Ishibashi, Masashi Kameyama, Tensho Yamao, Kenta Miwa, Masayo Ogawa, Noriko Sato
Publikováno v:
Frontiers in Neurology, Vol 11 (2021)
Background: In clinical practice, equivocal findings are inevitable in visual interpretation of whether amyloid positron emission tomography (PET) is positive or negative. It is therefore necessary to establish a more objective quantitative evaluatio
Externí odkaz:
https://doaj.org/article/d804d17c8fd748caaeff8ee67474d60b
Autor:
John Devin Peipert, Austin G Kulasekararaj, Anna Gaya, Saskia M C Langemeijer, Susan Yount, F Ataulfo Gonzalez-Fernandez, Emilio Ojeda Gutierrez, Christa Martens, Amy Sparling, Kimberly A Webster, David Cella, Ioannis Tomazos, Masayo Ogawa, Caroline I Piatek, Richard Wells, Flore Sicre de Fontbrune, Alexander Röth, Lindsay Mitchell, Anita Hill, Karen Kaiser
Publikováno v:
PLoS ONE, Vol 15, Iss 9, p e0237497 (2020)
BackgroundEculizumab has transformed management of paroxysmal nocturnal hemoglobinuria (PNH) since its approval. However, its biweekly dosing regimen remains a high treatment burden. Ravulizumab administered every 8 weeks demonstrated noninferiority
Externí odkaz:
https://doaj.org/article/f886a2dbac2e4004b37122b11f34a4e1
Autor:
Daichi Sone, Yoko Shigemoto, Masayo Ogawa, Norihide Maikusa, Kyoji Okita, Harumasa Takano, Koichi Kato, Noriko Sato, Hiroshi Matsuda
Publikováno v:
Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring, Vol 12, Iss 1, Pp n/a-n/a (2020)
Abstract Introduction The molecular mechanism of neurodegeneration, including tau and neurite complexity, is an important topic in Alzheimer's disease (AD) research. Methods We recruited 27 amyloid‐positive individuals identified through 11C‐Pitt
Externí odkaz:
https://doaj.org/article/485f42cb1658427ab7ef80ce0d8fb789
Autor:
Masayo Ogawa, Daichi Sone, Iman Beheshti, Norihide Maikusa, Kyoji Okita, Harumasa Takano, Hiroshi Matsuda
Publikováno v:
Heliyon, Vol 5, Iss 6, Pp e01828- (2019)
Cognitive assessments and neuroimaging are routinely combined in clinical practice to diagnose dementia represented by Alzheimer's disease (AD). The Montreal Cognitive Assessment (MoCA) is reported to be more suitable than the Mini-Mental State Exami
Externí odkaz:
https://doaj.org/article/192cc940fd3240b89f8f2b96271d7e1b
Autor:
Austin G. Kulasekararaj, Morag Griffin, Saskia Langemeijer, Kensuke Usuki, Alexander Kulagin, Masayo Ogawa, Ji Yu, Arshad Mujeebuddin, Jun-ichi Nishimura, Jong Wook Lee, Régis Peffault de Latour
Publikováno v:
Future Rare Diseases.
What is this summary about? Eculizumab and ravulizumab are approved treatments for paroxysmal nocturnal hemoglobinuria (PNH), a rare blood disease which can cause potentially fatal complications if left untreated. Long-term ravulizumab treatment in p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8369a73c3ea5ad7c7c24ecfddc628f26
https://doi.org/10.2217/frd-2022-0024
https://doi.org/10.2217/frd-2022-0024